Clinical Trials
24 trialsNCT05546476 2026-06-03
PROACC-1
Pfizer
Phase 2 Completed
NCT04757519 2026-01-23
Enhanced DPP-GLB to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention.
University of Kentucky
Phase NA Active not recruiting
NCT04844970 2025-11-17
Anamorelin Study for Advanced Pancreatic Cancer
Lahey Clinic
Phase 2 Terminated
NCT03035409 2025-11-10
Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT01785719 2025-02-03
Evaluation of Ovarian Morphology and Function in Overweight Women During Weight Loss
Cornell University
Phase NA Completed
NCT04741802 2024-02-28
TOPS for African American Breast Cancer Survivors
Duke University
Phase NA Completed
NCT04803305 2024-01-12
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Pfizer
Phase 1 Completed
NCT04299048 2023-12-14
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
Pfizer
Phase 1 Completed
NCT03329079 2023-10-04
Engaging Rural Men With Mobile Technologies for Weight Loss
University of Nebraska
Phase NA Completed
NCT02664441 2022-05-05
ECHO
Seattle Children's Hospital
Phase 3 Completed
NCT03480022 2021-06-07
SAXAPCOS
Woman's
Phase 3 Completed
NCT01302379 2020-06-05
Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors
University of California, San Diego
Phase NA Completed
NCT02530515 2019-10-29
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00475982 2019-01-31
Effect of Weight Loss on Prostate Cancer Pathology
VA Office of Research and Development
Phase NA Completed
NCT02269631 2019-01-25
Legume Diet Satiety Pilot Study
Emory University
Phase NA Completed
NCT00832520 2018-04-10
Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
New Mexico Cancer Research Alliance
Phase 2 Terminated
NCT02100189 2017-05-11
Esophageal Cytology With FISH in Detecting Esophageal Cancer
OHSU Knight Cancer Institute
Phase NA Completed
NCT00637728 2016-06-23
Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients
Par Pharmaceutical, Inc.
Phase 3 Terminated
NCT00558558 2016-05-13
Haelan and Nutrition in Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00637806 2016-05-02
Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension
Par Pharmaceutical, Inc.
Phase 3 Terminated
NCT00625742 2016-02-12
Multimodal Treatment Strategy for Cancer Cachexia
M.D. Anderson Cancer Center
Phase NA Terminated
NCT00513357 2012-12-11
Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00412425 2012-05-04
Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT00561977 2011-09-02
CanDo
University of Massachusetts, Worcester
Phase NA Completed